Related Experiment Video
Updated: Jul 14, 2025
05:31
Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
854
Micro RNA210 expression in pregnancies with preeclampsia.
Shali Paremmal1, Nidhi Sharma2, Rama Devi3
1Department of Anatomy, Government Medical College Mahabubnagar, Telangana.
Bioinformation
|October 9, 2023
Summary
MicroRNAs, specifically micro RNA 210 (miRNA210), are implicated in preeclampsia pathogenesis. This study found a 2.7-fold upregulation of miRNA210 in preeclamptic placentas, suggesting its role in the condition.
Area of Science:
- Biochemistry
- Genetics
- Obstetrics
Background:
- Preeclampsia is a leading cause of perinatal complications with unknown etiology.
- MicroRNAs (miRNAs) are key gene expression regulators in health and disease.
- miRNA210, a hypoxamir, influences cellular processes like apoptosis and metabolism.
Purpose of the Study:
- To investigate the expression pattern of miRNA210 in preeclampsia.
- To explore the potential role of miRNA210 in understanding preeclampsia pathogenesis.
Main Methods:
- Placental tissues were collected from age-matched control and preeclamptic patients.
- Inclusion and exclusion criteria were strictly applied for patient selection.
- Quantitative reverse transcription polymerase chain reaction (qRT-PCR) was used to analyze miRNA210 expression.
Main Results:
- A significant 2.7-fold upregulation of miRNA210 was observed in preeclamptic placentas compared to controls.
- This finding suggests a potential link between miRNA210 dysregulation and preeclampsia.
Conclusions:
- miRNA210 is upregulated in preeclampsia, indicating its involvement in the condition's pathophysiology.
- Further research is warranted to elucidate the precise role of miRNA210 in preeclampsia pathogenesis.
